Tower Research Capital (TRC)’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.9K Sell
5,541
-8,429
-60% -$113K ﹤0.01% 2477
2025
Q4
$176K Buy
13,970
+9,261
+197% +$106K ﹤0.01% 1536
2025
Q3
$47.1K Sell
4,709
-13,059
-73% -$117K ﹤0.01% 2570
2025
Q2
$144K Buy
17,768
+14,855
+510% +$112K ﹤0.01% 2082
2025
Q1
$24.4K Buy
2,913
+1,136
+64% +$9.48K ﹤0.01% 2784
2024
Q4
$14.1K Buy
1,777
+974
+121% +$8.17K ﹤0.01% 3481
2024
Q3
$6.68K Sell
803
-26,786
-97% -$209K ﹤0.01% 4118
2024
Q2
$175K Buy
27,589
+24,671
+845% +$157K ﹤0.01% 2177
2024
Q1
$17.7K Sell
2,918
-31,516
-92% -$178K ﹤0.01% 3106
2023
Q4
$209K Buy
34,434
+29,775
+639% +$133K ﹤0.01% 2070
2023
Q3
$19.7K Sell
4,659
-6,506
-58% -$24.3K ﹤0.01% 3391
2023
Q2
$34.6K Buy
11,165
+6,089
+120% +$13K ﹤0.01% 2893
2023
Q1
$7K Sell
5,076
-3,363
-40% -$6.7K ﹤0.01% 4711
2022
Q4
$17K Buy
8,439
+1,077
+15% +$2.41K ﹤0.01% 3257
2022
Q3
$15K Buy
7,362
+484
+7% +$1.36K ﹤0.01% 4150
2022
Q2
$22K Buy
6,878
+4,529
+193% +$16.4K ﹤0.01% 3681
2022
Q1
$9K Sell
2,349
-275
-10% -$1.22K ﹤0.01% 4426
2021
Q4
$13K Sell
2,624
-7,491
-74% -$37.3K ﹤0.01% 4145
2021
Q3
$54K Sell
10,115
-5,028
-33% -$25.3K ﹤0.01% 2890
2021
Q2
$78K Buy
15,143
+5,184
+52% +$29.5K ﹤0.01% 2624
2021
Q1
$67K Sell
9,959
-32,711
-77% -$181K ﹤0.01% 2879
2020
Q4
$195K Sell
42,670
-96,662
-69% -$428K 0.01% 1724
2020
Q3
$540K Buy
139,332
+104,203
+297% +$446K 0.01% 1598
2020
Q2
$167K Buy
+35,129
New +$145K 0.01% 1959
2019
Q4
Sell
-5,413
Closed -$16K 3477
2019
Q3
$16K Sell
5,413
-2,353
-30% -$8.21K ﹤0.01% 2601
2019
Q2
$56K Buy
7,766
+6,894
+791% +$70.5K ﹤0.01% 1519
2019
Q1
$12K Sell
872
-828
-49% -$10.9K ﹤0.01% 2559
2018
Q4
$23K Buy
+1,700
New +$30.6K ﹤0.01% 1813

Other funds holding AMRX